England’s prescribing trends provide a host of intriguing insights
Data can tell interesting stories, and I’ve seen a few when working on Wilmington’s latest insight compendium, State of the Nation.
The review covers hospital episode statistics, demographics and inequalities, performance, therapy area analysis and workforce, among other fields.
For now, it’s the prescribing data I want to explore.
Figures from the past few months are in and the trends are clear – hospital prescribing is providing the biggest area of growth in spending; there’s wide variation in how much different integrated care systems spend on drugs per head. Diabetes, anticoagulant and respiratory drugs are driving growth in primary care, whereas in secondary care it’s all about oncology and immunology biologics.
Check out the rest of this feature here